Please login to the form below

Not currently logged in
Email:
Password:

CROS NT appoints Renee Covell as head of US operation

She brings over 20 years of experience to the contract research organisation

edit-Renee-PortraitContract research organisation CROS NT has appointed Dr Renee Covell to head its US operations.

Covell has 16 years of experience in the industry, including roles at LabCorp, Covance, Synteract and AAC Business Consulting, which she owns. She is also professor of business at Penn State University, US.

She said: “I am thrilled by the opportunity to bring the high levels of quality and customer service, synonymous with CROS NT, to a wider US audience. I share the values that underpin CROS NT, which made the decision to come on board very easy.”

In her new role, Covell will take responsibility for all of the company's activities in the USA and work with the senior management teams to advance and execute the global strategy.

Andrew MacGarvey, CEO at CROS NT, added: “I am delighted to welcome Dr Covell to the team. Her combination of industry expertise and leadership skills is perfectly suited to this important role. I know that she will contribute across all areas of our business and will be a valuable member of the team.”

Covell's appointment follows CROS NT's successful acquisition of Stat-Tech Services last year and a subsequent growth in its customer base.

8th October 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics